Table 2 Echocardiographic parameters in critically ill patients with coronavirus-19 sepsis according to survival at day 28
All patients (n = 67) | Survivors (n = 41) | Non-survivors (n = 26) | p value | |
|---|---|---|---|---|
Preload | ||||
Maximal IVC diameter (mm) | 22 (18–25) | 23 (19–26) | 21 (16–26) | 0.36 |
E/A ratio at mitral valve | 1.0 (0.8–1.3) | 1.1 (0.9–1.3) | 0.8 (0.6–1.1) | < 0.01 |
E/e′ ratio at mitral valve | 7 (6–9) | 7 (5–8) | 7 (6–10) | 0.18 |
LV contractility | ||||
LVEF (%) | 60 (49–67) | 61 (52–69) | 54 (42–67) | 0.30 |
AS (%) | 14.8 (17.9–10.2) | 15.6 (10.9–18.4) | 12.1 (9.1–16.7) | 0.12 |
sm (cm s−1) | 11 (9–13) | 11 (10–16) | 11 (10–16) | 0.29 |
VAC | 1.9 (1.0–3.0) | 2.0 (1.5–2.9) | 1.3 (0.8–3.4) | 0.17 |
ME (mmHg mL−1) | 3.6 (1.8–5.0) | 3.9 (2.5–4.7) | 2.7 (1.5–6.1) | 0.36 |
LV afterload | ||||
AE (mmHg mL−1 μg−1 kg min) | 1.8 (1.6–2.1) | 1.7 (1.6–2.0) | 1.8 (1.6–2.2) | 0.30 |
SVR (mmHg L−1 min) | 1096 (908–1245) | 1102 (921–1384) | 1087 (899–1227) | 0.42 |
DAP (mmHg) | 57 (53–66) | 57 (55–66) | 56 (52–67) | 0.34 |
RV function | ||||
TAPSE (mm) | 21 (18–25) | 22 (20–25) | 19 (17–24) | 0.11 |
st (cm/s) | 13 (11–17) | 13 (11–17) | 14 (11–16) | 0.98 |
PCD | 0.31 | |||
0 | 28 (42%) | 15 (37%) | 13 (50%) | |
1 | 8 (12%) | 4 (10%) | 4 (15%) | |
2 | 31 (46%) | 22 (54%) | 9 (35%) | |
Global function | ||||
VTI LVOT (cm) | 18 (15–21) | 18 (15–21) | 18 (15–20) | 0.63 |
Systolic ejection volume (mL) | 69 (54–83) | 71 (60–85) | 68 (53–81) | 0.54 |
Heart rate (rpm) | 87 (73–100) | 84 (69–97) | 90 (76–105) | 0.09 |
Cardiac index (L min) | 2.9 (2.4–3.5) | 3.0 (2.4–3.4) | 2.9 (2.4–3.7) | 0.83 |